节点文献

药品集中采购政策的WHO经验及启示

Experience of WHO about Volume-Based Drug Procurement Policy

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 任延峰杨毅明坚孙辉刘柳鲍诗意陈英耀

【Author】 REN Yanfeng;YANG Yi;MING Jian;SUN Hui;LIU Liu;BAO Shiyi;CHEN Yingyao;School of Public Health, Fudan University, NHC Key Laboratory of Health Technology Assessment(Fudan University);

【通讯作者】 陈英耀;

【机构】 复旦大学公共卫生学院国家卫生健康委员会卫生技术评估重点实验室(复旦大学)艾昆纬企业管理咨询(上海)有限公司上海市卫生和健康发展研究中心

【摘要】 世界卫生组织于2020年发布的《国家药品定价政策指南》,对制定药品集中采购政策提出了许多有效建议,为我国药品集中采购政策的发展改革提供了启示:发挥政策协同作用,推动分类采购模式形成,完善集中采购药品质量评价体系,促进采购流程透明化,建立完善信息共享平台,持续监测药品质量。

【Abstract】 The Guideline for National Drug Pricing Policy issued by the World Health Organization(WHO) in 2020 put forward many effective suggestions for formulating volume-based drug procurement policies, and provided inspiration for the development and reform of our country’s volume-based drug procurement policies. It is suggested to enhance policy synergy and promote classified procurement models. It is also recommended to improve the quality evaluation system for volume-based drug procurement, promote the transparency of the procurement process, establish and improve the information sharing platform, and continuously monitor the quality of drugs.

  • 【文献出处】 卫生经济研究 ,Health Economics Research , 编辑部邮箱 ,2022年06期
  • 【分类号】R95
  • 【下载频次】525
节点文献中: 

本文链接的文献网络图示:

本文的引文网络